These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 36107246)
1. Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer. Zhang L; Zhang B; Li L; Ye Y; Wu Y; Yuan Q; Xu W; Wen X; Guo X; Nian S J Cancer Res Clin Oncol; 2023 May; 149(5):2243-2258. PubMed ID: 36107246 [TBL] [Abstract][Full Text] [Related]
2. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells. Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM mBio; 2021 Feb; 12(1):. PubMed ID: 33531395 [TBL] [Abstract][Full Text] [Related]
3. CD8 Huang Y; Jia A; Wang Y; Liu G Immunology; 2023 Jan; 168(1):30-48. PubMed ID: 36190809 [TBL] [Abstract][Full Text] [Related]
4. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy. Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H Front Immunol; 2020; 11():622509. PubMed ID: 33633741 [TBL] [Abstract][Full Text] [Related]
5. Cellular and Molecular Mechanisms of CD8 Verdon DJ; Mulazzani M; Jenkins MR Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027962 [TBL] [Abstract][Full Text] [Related]
6. Reinvigorating exhausted CD8 Hossain MA; Liu G; Dai B; Si Y; Yang Q; Wazir J; Birnbaumer L; Yang Y Med Res Rev; 2021 Jan; 41(1):156-201. PubMed ID: 32844499 [TBL] [Abstract][Full Text] [Related]
7. Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells. Bae EA; Seo H; Kim BS; Choi J; Jeon I; Shin KS; Koh CH; Song B; Kim IK; Min BS; Han YD; Shin SJ; Kang CY Cancer Res; 2018 Sep; 78(18):5315-5326. PubMed ID: 30012672 [TBL] [Abstract][Full Text] [Related]
8. Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection. Ferrando-Martinez S; Snell Bennett A; Lino E; Gehring AJ; Feld J; Janssen HLA; Robbins SH Front Immunol; 2021; 12():648420. PubMed ID: 34589081 [TBL] [Abstract][Full Text] [Related]
9. The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer. Zhang J; Lei F; Tan H Front Immunol; 2023; 14():1166128. PubMed ID: 37275913 [TBL] [Abstract][Full Text] [Related]
10. Use of Mass Cytometry to Profile Human T Cell Exhaustion. Winkler F; Bengsch B Front Immunol; 2019; 10():3039. PubMed ID: 32038613 [TBL] [Abstract][Full Text] [Related]
12. CD8 T-cell heterogeneity during T-cell exhaustion and PD-1-targeted immunotherapy. Ando S; Araki K Int Immunol; 2022 Oct; 34(11):571-577. PubMed ID: 35901837 [TBL] [Abstract][Full Text] [Related]
13. CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy. He QF; Xu Y; Li J; Huang ZM; Li XH; Wang X Brief Funct Genomics; 2019 Mar; 18(2):99-106. PubMed ID: 29554204 [TBL] [Abstract][Full Text] [Related]
14. CD8 Wang Q; Qin Y; Li B Cancer Lett; 2023 Apr; 559():216043. PubMed ID: 36584935 [TBL] [Abstract][Full Text] [Related]
15. A variety of 'exhausted' T cells in the tumor microenvironment. Nagasaki J; Togashi Y Int Immunol; 2022 Oct; 34(11):563-570. PubMed ID: 35460561 [TBL] [Abstract][Full Text] [Related]
16. CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions. Hashimoto M; Kamphorst AO; Im SJ; Kissick HT; Pillai RN; Ramalingam SS; Araki K; Ahmed R Annu Rev Med; 2018 Jan; 69():301-318. PubMed ID: 29414259 [TBL] [Abstract][Full Text] [Related]
17. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors. Khan SM; Desai R; Coxon A; Livingstone A; Dunn GP; Petti A; Johanns TM J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543376 [TBL] [Abstract][Full Text] [Related]
18. Strategies to reinvigorate exhausted CD8 Guan Q; Han M; Guo Q; Yan F; Wang M; Ning Q; Xi D Front Immunol; 2023; 14():1204363. PubMed ID: 37398660 [TBL] [Abstract][Full Text] [Related]
19. PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells. Balança CC; Salvioni A; Scarlata CM; Michelas M; Martinez-Gomez C; Gomez-Roca C; Sarradin V; Tosolini M; Valle C; Pont F; Ferron G; Gladieff L; Vergez S; Dupret-Bories A; Mery E; Rochaix P; Fournié JJ; Delord JP; Devaud C; Martinez A; Ayyoub M JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33332284 [TBL] [Abstract][Full Text] [Related]
20. T cell exhaustion and immune-mediated disease-the potential for therapeutic exhaustion. McKinney EF; Smith KG Curr Opin Immunol; 2016 Dec; 43():74-80. PubMed ID: 27744240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]